Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration
<i>Background and objectives:</i> Bisphosphonates represent selective inhibitors of excess osteoblastic bone resorption that characterizes all osteopathies, targeting osteoclasts and their precursors. Their long-term administration in postmenopausal women suffering from osteoporosis has...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1010-660X/56/3/140 |
id |
doaj-78de8dbafa4b42dba1c22d5927f35edb |
---|---|
record_format |
Article |
spelling |
doaj-78de8dbafa4b42dba1c22d5927f35edb2020-11-25T03:10:06ZengMDPI AGMedicina1010-660X2020-03-0156314010.3390/medicina56030140medicina56030140Immunohistochemical Femoral Nerve Study Following Bisphosphonates AdministrationVasileios Alexandros Karakousis0Danai Liouliou1Aikaterini Loula2Nikoleta Kagianni3Eva-Maria Dietrich4Soultana Meditskou5Antonia Sioga6Theodora Papamitsou7Laboratory of Histology and Embryology, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceLaboratory of Histology and Embryology, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceLaboratory of Histology and Embryology, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceLaboratory of Histology and Embryology, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceDepartment of Oral and Maxillofacial Surgery, University Hospital of Erlangen, 91054 Erlangen, GermanyLaboratory of Histology and Embryology, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceLaboratory of Histology and Embryology, Aristotle University of Thessaloniki, 54124 Thessaloniki, GreeceLaboratory of Histology and Embryology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece<i>Background and objectives:</i> Bisphosphonates represent selective inhibitors of excess osteoblastic bone resorption that characterizes all osteopathies, targeting osteoclasts and their precursors. Their long-term administration in postmenopausal women suffering from osteoporosis has resulted in neural adverse effects. The current study focuses on the research of possible alterations in the femoral nerve, caused by bisphosphonates. We hypothesized that bisphosphonates, taken orally (per os), may produce degenerative changes to the femoral nerve, affecting lower-limb posture and walking neuronal commands. <i>Materials and Methods:</i> In order to support our hypothesis, femoral nerve specimens were extracted from ten female 12-month-old Wistar rats given 0.05 milligrams (mg) per kilogram (kg) of body weight (b.w.) per week alendronate per os for 13 weeks and from ten female 12-month-old Wistar rats given normal saline that were used as a control group. Specimens were studied using immunohistochemistry for selected antibodies NeuN (Neuronal Nuclear Protein), a protein located within mature, postmitotic neural nucleus, and cytosol and Sox10 (Sex-determining Region Y (SRY)—High-Motility Group (HMG)—box 10). The latter marker is fundamental for myelination of peripheral nerves. Obtained slides were examined under a light microscope. <i>Results:</i> Samples extracted from rats given alendronate were more Sox10 positive compared to samples of the control group, where the marker’s expression was not so intense. Both groups were equally NeuN positive. Our results are in agreement with previous studies conducted under a transmission electron microscope. <i>Conclusions:</i> The suggested pathophysiological mechanism linked to histological alterations described above is possibly related to toxic drug effects on Schwann and neuronal cells. Our hypothesis enhances the existing scientific evidence of degenerative changes present on femoral nerve following bisphosphonates administration, indicating a possible relationship between alendronate use and neuronal function.https://www.mdpi.com/1010-660X/56/3/140bisphosphonatesfemoral nerveimmunohistochemistryneunsox10 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Vasileios Alexandros Karakousis Danai Liouliou Aikaterini Loula Nikoleta Kagianni Eva-Maria Dietrich Soultana Meditskou Antonia Sioga Theodora Papamitsou |
spellingShingle |
Vasileios Alexandros Karakousis Danai Liouliou Aikaterini Loula Nikoleta Kagianni Eva-Maria Dietrich Soultana Meditskou Antonia Sioga Theodora Papamitsou Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration Medicina bisphosphonates femoral nerve immunohistochemistry neun sox10 |
author_facet |
Vasileios Alexandros Karakousis Danai Liouliou Aikaterini Loula Nikoleta Kagianni Eva-Maria Dietrich Soultana Meditskou Antonia Sioga Theodora Papamitsou |
author_sort |
Vasileios Alexandros Karakousis |
title |
Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration |
title_short |
Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration |
title_full |
Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration |
title_fullStr |
Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration |
title_full_unstemmed |
Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration |
title_sort |
immunohistochemical femoral nerve study following bisphosphonates administration |
publisher |
MDPI AG |
series |
Medicina |
issn |
1010-660X |
publishDate |
2020-03-01 |
description |
<i>Background and objectives:</i> Bisphosphonates represent selective inhibitors of excess osteoblastic bone resorption that characterizes all osteopathies, targeting osteoclasts and their precursors. Their long-term administration in postmenopausal women suffering from osteoporosis has resulted in neural adverse effects. The current study focuses on the research of possible alterations in the femoral nerve, caused by bisphosphonates. We hypothesized that bisphosphonates, taken orally (per os), may produce degenerative changes to the femoral nerve, affecting lower-limb posture and walking neuronal commands. <i>Materials and Methods:</i> In order to support our hypothesis, femoral nerve specimens were extracted from ten female 12-month-old Wistar rats given 0.05 milligrams (mg) per kilogram (kg) of body weight (b.w.) per week alendronate per os for 13 weeks and from ten female 12-month-old Wistar rats given normal saline that were used as a control group. Specimens were studied using immunohistochemistry for selected antibodies NeuN (Neuronal Nuclear Protein), a protein located within mature, postmitotic neural nucleus, and cytosol and Sox10 (Sex-determining Region Y (SRY)—High-Motility Group (HMG)—box 10). The latter marker is fundamental for myelination of peripheral nerves. Obtained slides were examined under a light microscope. <i>Results:</i> Samples extracted from rats given alendronate were more Sox10 positive compared to samples of the control group, where the marker’s expression was not so intense. Both groups were equally NeuN positive. Our results are in agreement with previous studies conducted under a transmission electron microscope. <i>Conclusions:</i> The suggested pathophysiological mechanism linked to histological alterations described above is possibly related to toxic drug effects on Schwann and neuronal cells. Our hypothesis enhances the existing scientific evidence of degenerative changes present on femoral nerve following bisphosphonates administration, indicating a possible relationship between alendronate use and neuronal function. |
topic |
bisphosphonates femoral nerve immunohistochemistry neun sox10 |
url |
https://www.mdpi.com/1010-660X/56/3/140 |
work_keys_str_mv |
AT vasileiosalexandroskarakousis immunohistochemicalfemoralnervestudyfollowingbisphosphonatesadministration AT danailiouliou immunohistochemicalfemoralnervestudyfollowingbisphosphonatesadministration AT aikateriniloula immunohistochemicalfemoralnervestudyfollowingbisphosphonatesadministration AT nikoletakagianni immunohistochemicalfemoralnervestudyfollowingbisphosphonatesadministration AT evamariadietrich immunohistochemicalfemoralnervestudyfollowingbisphosphonatesadministration AT soultanameditskou immunohistochemicalfemoralnervestudyfollowingbisphosphonatesadministration AT antoniasioga immunohistochemicalfemoralnervestudyfollowingbisphosphonatesadministration AT theodorapapamitsou immunohistochemicalfemoralnervestudyfollowingbisphosphonatesadministration |
_version_ |
1724660596386824192 |